category 218 companies-and-people 
The Pharma Data
FEBRUARY 8, 2021
Q4 2020 sales growth (2) of 4.2% and business EPS growth of 9.8% Specialty Care sales grew 18.3%, driven by strong Dupixent ® performance (+54.2% to €982 million). Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. General Medicines declined 7.5%, reflecting lower U.S. Sales down 2.4%
The Pharma Data
FEBRUARY 4, 2021
Q4 2020 sales growth (2) of 4.2% and business EPS growth of 9.8% Specialty Care sales grew 18.3%, driven by strong Dupixent ® performance (+54.2% to €982 million). Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. General Medicines declined 7.5%, reflecting lower U.S. Sales down 2.4%
Pharmaceutical Technology
JUNE 20, 2023
Over the next two years, GlobalData’s thematic research unit shows further advancements in machine learning, falling into three main categories: technology, macroeconomic, and regulatory. The current tech landscape is rapidly evolving, with advancements in areas such as big data and conversational platforms.
Expert insights. Personalized for you.
52 
Let's personalize your content